Login
Home
Charts
Search
Watchlist
Products

Aarti Drugs Ltd

AARTIDRUGS·NSE
₹436.25+2.47%Wed, 23 Sept '26
Industry:Pharma - API
Indices:

Aarti Drugs Ltd

AARTIDRUGS
NSE
₹436.25
+2.47%
|Wed, 23 Sept '26
SOICxStockScans Reports
Industry
Pharma - API
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹3,982Cr
Close
Close Price
₹436.25
Industry
Industry
Pharma - API
PE
Price To Earnings
20.84
PS
Price To Sales
1.49
Revenue
Revenue
₹2,678Cr
Rev Gr TTM
Revenue Growth TTM
10.54%
PAT Gr TTM
PAT Growth TTM
1.22%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
642606620555598557677591653602720703
Growth YoY
Revenue Growth YoY%
-6.7-8.7-16.5-16.0-6.7-8.19.26.39.18.16.419.0
Expenses
ExpensesCr
565536534490531495583516569547625605
Operating Profit
Operating ProfitCr
767086656762937484559698
OPM
OPM%
11.911.613.811.711.211.113.812.612.99.213.314.0
Other Income
Other IncomeCr
121111220011-1
Interest Expense
Interest ExpenseCr
889999998989
Depreciation
DepreciationCr
131314131414151516181818
PBT
PBTCr
565264444651715160297069
Tax
TaxCr
1715171111148-315-121519
PAT
PATCr
403747333537635445415550
Growth YoY
PAT Growth YoY%
2.20.1-15.8-30.6-11.71.032.762.229.29.3-12.0-7.1
NPM
NPM%
6.26.17.66.05.86.79.39.16.96.77.77.1
EPS
EPS₹
4.34.05.23.63.84.16.95.95.04.46.05.5
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
642606620555598557677591653602720703
Growth YoY
Revenue Growth YoY%
-6.7-8.7-16.5-16.0-6.7-8.19.26.39.18.16.419.0
Expenses
ExpensesCr
565536534490531495583516569547625605
Operating Profit
Operating ProfitCr
767086656762937484559698
OPM
OPM%
11.911.613.811.711.211.113.812.612.99.213.314.0
Other Income
Other IncomeCr
121111220011-1
Interest Expense
Interest ExpenseCr
889999998989
Depreciation
DepreciationCr
131314131414151516181818
PBT
PBTCr
565264444651715160297069
Tax
TaxCr
1715171111148-315-121519
PAT
PATCr
403747333537635445415550
Growth YoY
PAT Growth YoY%
2.20.1-15.8-30.6-11.71.032.762.229.29.3-12.0-7.1
NPM
NPM%
6.26.17.66.05.86.79.39.16.96.77.77.1
EPS
EPS₹
4.34.05.23.63.84.16.95.95.04.46.05.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,1401,1951,2441,5611,8062,1552,4892,7162,5292,3872,5652,678
Growth
Revenue Growth%
3.94.84.025.515.719.315.59.1-6.9-5.67.510.5
Expenses
ExpensesCr
9641,0081,0451,3541,5441,7182,1592,4102,2122,1002,2562,344
Operating Profit
Operating ProfitCr
176187198207262437329306316287309333
OPM
OPM%
15.415.616.013.314.520.313.211.312.512.012.112.4
Other Income
Other IncomeCr
04166511241621
Interest Expense
Interest ExpenseCr
443635403423213334363434
Depreciation
DepreciationCr
373840434950505051566771
PBT
PBTCr
95116125131185369270224236212211229
Tax
TaxCr
273442414489655864441638
PAT
PATCr
69828290141280205166172168195191
Growth
PAT Growth%
-11.019.00.69.157.598.3-26.9-18.93.1-2.016.01.2
NPM
NPM%
6.06.86.65.87.813.08.26.16.87.07.67.1
EPS
EPS₹
7.18.48.69.615.130.122.118.018.618.421.420.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,1401,1951,2441,5611,8062,1552,4892,7162,5292,3872,5652,678
Growth
Revenue Growth%
3.94.84.025.515.719.315.59.1-6.9-5.67.510.5
Expenses
ExpensesCr
9641,0081,0451,3541,5441,7182,1592,4102,2122,1002,2562,344
Operating Profit
Operating ProfitCr
176187198207262437329306316287309333
OPM
OPM%
15.415.616.013.314.520.313.211.312.512.012.112.4
Other Income
Other IncomeCr
04166511241621
Interest Expense
Interest ExpenseCr
443635403423213334363434
Depreciation
DepreciationCr
373840434950505051566771
PBT
PBTCr
95116125131185369270224236212211229
Tax
TaxCr
273442414489655864441638
PAT
PATCr
69828290141280205166172168195191
Growth
PAT Growth%
-11.019.00.69.157.598.3-26.9-18.93.1-2.016.01.2
NPM
NPM%
6.06.86.65.87.813.08.26.16.87.07.67.1
EPS
EPS₹
7.18.48.69.615.130.122.118.018.618.421.420.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2424242423939393929191
Reserves
ReservesCr
3333764325206298209441,1001,1901,2781,458
Current Liabilities
Current LiabilitiesCr
501494622591623595940933796837922
Non Current Liabilities
Non Current LiabilitiesCr
244297312321301257232296355368344
Total Liabilities
Total LiabilitiesCr
1,1021,1911,3891,4551,5771,7662,2082,4212,4322,5752,815
Current Assets
Current AssetsCr
5655717377848991,0571,3931,4921,3211,3381,468
Non Current Assets
Non Current AssetsCr
5376206536716777098159291,1121,2361,347
Total Assets
Total AssetsCr
1,1021,1911,3891,4551,5771,7662,2082,4212,4322,5752,815
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2424242423939393929191
Reserves
ReservesCr
3333764325206298209441,1001,1901,2781,458
Current Liabilities
Current LiabilitiesCr
501494622591623595940933796837922
Non Current Liabilities
Non Current LiabilitiesCr
244297312321301257232296355368344
Total Liabilities
Total LiabilitiesCr
1,1021,1911,3891,4551,5771,7662,2082,4212,4322,5752,815
Current Assets
Current AssetsCr
5655717377848991,0571,3931,4921,3211,3381,468
Non Current Assets
Non Current AssetsCr
5376206536716777098159291,1121,2361,347
Total Assets
Total AssetsCr
1,1021,1911,3891,4551,5771,7662,2082,4212,4322,5752,815

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1331757014325115570133359245254
Investing Cash Flow
Investing Cash FlowCr
-99-107-74-62-33-72-150-164-224-165-173
Financing Cash Flow
Financing Cash FlowCr
-33-684-80-215-819217-136-82-77
Net Cash Flow
Net Cash FlowCr
1-1012213-14-1-23
Free Cash Flow
Free Cash FlowCr
3467-56921478-82-311336780
CFO To PAT
CFO To PAT%
194.0213.484.8159.4177.355.334.480.1209.2145.5130.1
CFO To EBITDA
CFO To EBITDA%
75.993.435.169.095.835.521.443.6113.485.282.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1331757014325115570133359245254
Investing Cash Flow
Investing Cash FlowCr
-99-107-74-62-33-72-150-164-224-165-173
Financing Cash Flow
Financing Cash FlowCr
-33-684-80-215-819217-136-82-77
Net Cash Flow
Net Cash FlowCr
1-1012213-14-1-23
Free Cash Flow
Free Cash FlowCr
3467-56921478-82-311336780
CFO To PAT
CFO To PAT%
194.0213.484.8159.4177.355.334.480.1209.2145.5130.1
CFO To EBITDA
CFO To EBITDA%
75.993.435.169.095.835.521.443.6113.485.282.0

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,1011,3731,1951,5101,1796,4763,9733,1283,9893,1012,9153,982
Price To Earnings
Price To Earnings
16.816.814.516.88.323.119.418.823.318.414.920.8
Price To Sales
Price To Sales
1.01.11.01.00.73.01.61.11.61.31.11.5
Price To Book
Price To Book
3.13.42.62.81.87.13.82.63.12.31.92.6
EV To EBITDA
EV To EBITDA
8.89.78.69.55.815.613.612.214.412.911.313.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.924.024.620.722.928.420.718.619.920.821.521.5
OPM
OPM%
15.415.616.013.314.520.313.211.312.512.012.112.4
NPM
NPM%
6.06.86.65.87.813.08.26.16.87.07.67.1
ROCE
ROCE%
17.218.016.616.921.931.018.414.314.612.511.511.5
ROE
ROE%
19.220.418.116.521.730.719.813.913.412.312.612.6
ROA
ROA%
6.26.95.96.29.015.99.36.97.06.56.96.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,1011,3731,1951,5101,1796,4763,9733,1283,9893,1012,9153,982
Price To Earnings
Price To Earnings
16.816.814.516.88.323.119.418.823.318.414.920.8
Price To Sales
Price To Sales
1.01.11.01.00.73.01.61.11.61.31.11.5
Price To Book
Price To Book
3.13.42.62.81.87.13.82.63.12.31.92.6
EV To EBITDA
EV To EBITDA
8.89.78.69.55.815.613.612.214.412.911.313.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.924.024.620.722.928.420.718.619.920.821.521.5
OPM
OPM%
15.415.616.013.314.520.313.211.312.512.012.112.4
NPM
NPM%
6.06.86.65.87.813.08.26.16.87.07.67.1
ROCE
ROCE%
17.218.016.616.921.931.018.414.314.612.511.511.5
ROE
ROE%
19.220.418.116.521.730.719.813.913.412.312.612.6
ROA
ROA%
6.26.95.96.29.015.99.36.97.06.56.96.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Aarti Drugs Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/yv358nly3oqb3vgz7kq31xki.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/9pj23cq8zyd6kwfiplg9onkm.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/0efm662c7q9zjbkhlhzpgg86.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/8dlfrneh8s3k8tv46isvm367.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/n8kxkht2kz9y01qtz3fifsxa.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/jy4t558yf0vfm1m6qc38yww8.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/okbdj44cwwtgf3dlp2kt70e5.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/tp18xb3jys4ph2eju4xinla6.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/9x9az11vp1ffks3rw263ueu2.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/1tz8wvrgvaoci3c1s4bu3xug.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/kedsrwzpyk1bkqgdqa2gy5nw.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/9tukox4wtfndnzxfy72r3etl.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/5afz92vwt2y2ps7z391gc65c.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/1v185xyf97qm208ftqde4svq.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/v8wiz7d8c7dyhzv8dfx9idtk.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/5j6cml8v9o8t9kxdt8gj3x39.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/xw286vti1mtptfwcnamz5oh5.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/27hajq1fmv97j4ncmk1qfl81.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/anmil9kxznsham7nt4k61s92.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/5hdueatzwf4r9o6wu1efjwas.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/3n6r7kdejxc3isw73txs2knk.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/j20j32vwycj7uyb3eqvf7sk6.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/22jaxq4kuzfswzmtcgxtoc33.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/tdvn1kho61a8fctnzar4nndu.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/zojp1ehtvh1q8v25l2a9yner.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/k5xqils5t309owgvlflwgoa7.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/o7ondd9i8gkg7catvhc6rmef.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/klzbtozbhyi3hdlwoshw5zry.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/2q74f84pckcpv99k25o55zkm.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/j51jj1fdubwxrhhoy7prwk63.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/9w3106vt2ke5926ckc2cjaij.pdf

Concall Transcript Summaries — Aarti Drugs Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AAARTIDRUGS/transcript-notes/202606/yv358nly3oqb3vgz7kq31xki.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AAARTIDRUGS/transcript-notes/202603/9pj23cq8zyd6kwfiplg9onkm.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AAARTIDRUGS/transcript-notes/202512/0efm662c7q9zjbkhlhzpgg86.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AAARTIDRUGS/transcript-notes/202509/8dlfrneh8s3k8tv46isvm367.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AAARTIDRUGS/transcript-notes/202506/n8kxkht2kz9y01qtz3fifsxa.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AAARTIDRUGS/transcript-notes/202503/jy4t558yf0vfm1m6qc38yww8.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AAARTIDRUGS/transcript-notes/202412/okbdj44cwwtgf3dlp2kt70e5.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AAARTIDRUGS/transcript-notes/202409/tp18xb3jys4ph2eju4xinla6.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies